Literature DB >> 9164889

The pacemaker syndrome -- a matter of definition.

K A Ellenbogen, D M Gilligan, M A Wood, C Morillo, S S Barold.   

Abstract

Pacemaker syndrome is an iatrogenic disease that is often underdiagnosed. We propose that pacemaker syndrome represents the clinical consequences of suboptimal atrioventricular (AV) synchrony or AV dyssynchrony, regardless of the pacing mode. Clinicians implanting and programming pacemakers should attempt to optimize AV synchrony to prevent the occurrence of pacemaker syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9164889     DOI: 10.1016/s0002-9149(97)00085-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Heart Rhythm Society: expert consensus statements-part 1.

Authors:  Susie Sennhauser; Rishi Anand; Fred Kusumoto; Nora Goldschlager
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

2.  Dizzy spells in a patient with hypertrophic obstructive cardiomyopathy and a pacemaker.

Authors:  J M Wilschut; W G de Voogt
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

3.  First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization.

Authors:  S Serge Barold; Arzu Ilercil; Fabio Leonelli; Bengt Herweg
Journal:  J Interv Card Electrophysiol       Date:  2007-03-02       Impact factor: 1.900

4.  A case of pacemaker and pacemaker-like syndrome.

Authors:  Amir Kashani; Ali Mehdirad; Carey Fredman; Kurt Biermann; S Serge Barold
Journal:  J Interv Card Electrophysiol       Date:  2003-12       Impact factor: 1.900

5.  New concepts in pacemaker syndrome.

Authors:  D Michael Farmer; N A Mark Estes; Mark S Link
Journal:  Indian Pacing Electrophysiol J       Date:  2004-10-01

Review 6.  Indications for permanent pacing in dogs and cats.

Authors:  R A Santilli; F Giacomazzi; D M Porteiro Vázquez; M Perego
Journal:  J Vet Cardiol       Date:  2019-01-29       Impact factor: 1.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.